Montesinos-Rongen M, Küppers R, Schlüter D, Spieker T, Van Roost D, Schaller C, Reifenberger G, Wiestler O D, Deckert-Schlüter M
Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany.
Am J Pathol. 1999 Dec;155(6):2077-86. doi: 10.1016/S0002-9440(10)65526-5.
Primary central nervous system lymphomas (PCNSLs) have recently received considerable clinical attention due to their increasing incidence. To clarify the histogenetic origin of these intriguing neoplasms, PCNSLs from 10 HIV-negative patients were analyzed for immunoglobulin (Ig) gene rearrangements. All tumors exhibited clonal IgH gene rearrangements. Of the 10 cases, 5 used the V4-34 gene segment, and all of these lymphomas shared an amino acid exchange from glycine to aspartate due to a mutation in the first codon of the complementarity-determining region 1. No preferential usage of D(H), J(H), V(kappa), J(kappa), V(lambda), or J(lambda) gene segments was observed. All potentially functional rearrangements exhibited somatic mutations. The pattern of somatic mutations indicated selection of the tumor cells (or their precursors) for expression of a functional antibody. Mean mutation frequencies of 13. 2% and 8.3% were detected for the heavy and light chains, respectively, thereby exceeding other lymphoma entities. Cloning experiments of three tumors showed ongoing mutation in at least one case. These data suggest that PCNSLs are derived from highly mutated germinal-center B cells. The frequent usage of the V4-34 gene and the presence of a shared replacement mutation may indicate that the tumor precursors recognized a shared (super) antigen.
原发性中枢神经系统淋巴瘤(PCNSLs)由于其发病率不断上升,最近受到了临床的广泛关注。为了阐明这些引人关注的肿瘤的组织发生起源,对10例HIV阴性患者的PCNSLs进行了免疫球蛋白(Ig)基因重排分析。所有肿瘤均表现出克隆性IgH基因重排。在这10例病例中,5例使用了V4-34基因片段,并且所有这些淋巴瘤由于互补决定区1第一个密码子的突变,均存在从甘氨酸到天冬氨酸的氨基酸交换。未观察到D(H)、J(H)、V(kappa)、J(kappa)、V(lambda)或J(lambda)基因片段的优先使用情况。所有潜在的功能性重排均表现出体细胞突变。体细胞突变模式表明肿瘤细胞(或其前体)被选择用于表达功能性抗体。重链和轻链的平均突变频率分别检测到13.2%和8.3%,从而超过了其他淋巴瘤实体。对三个肿瘤的克隆实验显示至少有一个病例存在持续突变。这些数据表明PCNSLs来源于高度突变的生发中心B细胞。V4-34基因的频繁使用和共享替代突变的存在可能表明肿瘤前体识别了一种共享(超级)抗原。